Design, synthesis and pharmacological evaluation of β-carboline derivatives as potential antitumor agent via targeting autophagy

Eur J Med Chem. 2023 Jan 15:246:114955. doi: 10.1016/j.ejmech.2022.114955. Epub 2022 Nov 26.

Abstract

A series of novel β-carboline derivatives was designed, synthesized and evaluated as potential anticancer agents. Among them, compound 6g showed the most potent antiproliferative activity against the 786-0, HT-29 and 22RV1 cell lines with IC50 values of 2.71, 2.02, and 3.86 μM, respectively. The antitumor efficiency of compound 6gin vivo was also evaluated, and the results revealed that compound 6g significantly suppressed tumor development and reduced tumor weight in a mouse colorectal cancer homograft model. Further investigation on mechanisms of action demonstrated that compound 6g inhibited HCT116 cell growth by stimulating the ATG5/ATG7-dependent autophagic pathway. These molecules might be served as candidates for further development of colorectal cancer therapy agent.

Keywords: ATG5/ATG7; Antitumor; Autophagy; Colorectal cancer; Synthesis; β-Carboline.

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Autophagy
  • Carbolines
  • Cell Line, Tumor
  • Cell Proliferation
  • Colorectal Neoplasms* / drug therapy
  • Drug Screening Assays, Antitumor
  • HT29 Cells
  • Humans
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Carbolines